Table 3.
Surface applicators, electronic brachytherapy.
| Author | Year | Histology | N. Lesions N. patients | N. Fractions | Dose/Fraction | Total dose | Frequency | Median follow up | Local control |
|---|---|---|---|---|---|---|---|---|---|
| Bhatnagar et al. (92) | 2013 | NMSC | 171 lesions 122 patients | 8 | 5 Gy | 40 Gy | Twice a week | 10 months | 100% |
| Doggett et al. (93) | 2015 | NMSC | 524 lesions 524 patients | 8 | 5 Gy | 40 Gy | Twice a week | 12.5 months | 100% |
| Paravati et al. (94) | 2015 | BCC (149) Other (5) |
154 lesions 127 patients | 8 | 5 Gy | 40 Gy | Twice a week | 16.1 months | 99% |
| Goyal et al. (95) | 2015 | BCC (20) SCC (3) |
23 lesions 19 patients | 8–20 (mean 10) |
4 Gy – in 20 lesions | Mean 40 (32–50) | Daily | 12 months | 100% |
| Ballester-Sanchez et al. (96) | 2016 | BCC (40) | 40 lesions 40 patients | 6 6 |
6.1 Gy 7 Gy |
36.6 Gy 42 Gy |
Twice a week | At least 1 year | 90% 95% |
| Bhatnagar et al. (97) | 2016 | BCC (990) SCC (670) Other (88) |
1,822 lesions 1,259 patients | 3–8 | 5 Gy | 40–45 Gy | 2–3 times a week | 4–16 months | 99% |
| Patel et al. (98) | 2017 | BCC (113) SCC (95) |
208 lesions 188 patients | 8–10 | 4–5 Gy | 32–50 Gy | Twice a week | 3.3 years | 99.5% |
| Goyal et al. (95) | 2021 | BCC (28) SCC (22) |
50 lesions 33 patients | 8 | 5 Gy | 40 Gy | Twice a week | 45.6 months | 98% |
| Cerrolaza et al. (99) | 2021 | BCC (19) SCC (5) Other (11) |
35 lesions 35 patients | 8–10 | 5 Gy | 40–50 Gy | 1–2 times a week | 4.6 months | 100% |